2013
DOI: 10.1517/13543776.2013.818133
|View full text |Cite
|
Sign up to set email alerts
|

Integrin modulators: a patent review

Abstract: Integrins have been proven to be valuable therapeutic targets in the treatment of several inflammatory and autoimmune diseases, where leukocyte adhesion processes are regulated by them. Furthermore, they play an important role in pathological angiogenesis and tumor metastasis, being a promising target for cancer therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
61
0
3

Year Published

2014
2014
2018
2018

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 66 publications
(64 citation statements)
references
References 127 publications
0
61
0
3
Order By: Relevance
“…Although this effect of av inhibition may destabilize the protective fibrous cap, 49 it remains unknown whether integrin inhibitors will show similar effects on endothelial and smooth muscle phenotype in advanced atherosclerotic plaques. With multiple avb3 antagonists currently undergoing clinical trials for the treatment of psoriasis, arthritis, and cancer, 50 the use of these agents in patients at risk of cardiovascular events should be carefully weighed. ajp.amjpathol.org -The American Journal of Pathology…”
Section: Flow-induced Inflammation Requires Avb3mentioning
confidence: 99%
“…Although this effect of av inhibition may destabilize the protective fibrous cap, 49 it remains unknown whether integrin inhibitors will show similar effects on endothelial and smooth muscle phenotype in advanced atherosclerotic plaques. With multiple avb3 antagonists currently undergoing clinical trials for the treatment of psoriasis, arthritis, and cancer, 50 the use of these agents in patients at risk of cardiovascular events should be carefully weighed. ajp.amjpathol.org -The American Journal of Pathology…”
Section: Flow-induced Inflammation Requires Avb3mentioning
confidence: 99%
“…Although the roles of a number of cytoskeletal genes and proteins mediated by HBx have not been determined, the reviewed studies provide insights into the function of these factors in the development of HBV-associated HCC. Chemotherapeutic agents that are able to induce stabilization of cytoskeleton-associated proteins to restrict movement, as well as limit intracellular processes, have been studied as potential therapeutic agents for certain tumors (46,73). Therefore, it is possible that clarifying the underlying regulatory mechanisms of cytoskeleton-associated proteins during HBV infection may facilitate the identification of novel potential therapeutic targets for HBV-associated HCC.…”
Section: Resultsmentioning
confidence: 99%
“…Integrins are heterodimeric transmembrane adhesion receptors composed of 18 α-subunits and 8 β-subunits, and may recognize specific peptide motifs located in ECM components, including fibronectin, vitronectin, laminin, hyaluronan and collagen (46,47). HBV replication reduces the formation of focal adhesions and the actin concentration at the cell periphery, resulting in a significant reduction of adhesion to laminin in cells infected with HBV (48).…”
Section: The Cellular Cytoskeletal Proteins Associated With Cell Adhementioning
confidence: 99%
“…MK0429: MK0429 is a small, active, potent, non-peptide αvβ3 integrin inhibitor [23,56]. It functions to have potent inhibition activity for osteoclast formation and osteoclastic bone resorption.…”
Section: Integrin Antagonists In Tumor and Angiogenesis Inhibitionmentioning
confidence: 99%